Salona Global Medical Device Corporation (TSE:EVMT) has released an update.
Evome Medical Technologies Inc. has announced a positive turnaround with their fiscal year 2023 results, achieving a strong fourth quarter that led to a positive annual Adjusted EBITDA. The company generated annual revenues of $62.6 million and a gross margin of $22.5 million, marking a significant recovery from a challenging first half of the year. The turnaround strategy included restructuring debt, divesting non-core units, and launching new products, with plans for continued growth and debt reduction.
For further insights into TSE:EVMT stock, check out TipRanks’ Stock Analysis page.
